RecruitingPhase 3NCT06403501

Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris

Studying Anterior cutaneous nerve entrapment syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Intervention
Clascoterone(drug)
Enrollment
692 enrolled
Eligibility
12 years · All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06403501 on ClinicalTrials.gov

Other trials for Anterior cutaneous nerve entrapment syndrome

Additional recruiting or active studies for the same condition.

See all trials for Anterior cutaneous nerve entrapment syndrome

← Back to all trials